{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["African traditional plants", "Annickia chlorantha", "acetogenins", "cancer", "drug discovery", "medicinal plants", "natural products", "phytochemicals", "protoberberines"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36079675", "DateRevised": {"Year": "2022", "Month": "09", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "02"}], "Language": ["eng"], "ELocationID": ["2293", "10.3390/plants11172293"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "11", "Issue": "17", "PubDate": {"Year": "2022", "Month": "Sep", "Day": "02"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "A Review on Traditionally Used African Medicinal Plant <i>Annickia chlorantha</i>, Its Phytochemistry, and Anticancer Potential.", "Abstract": {"AbstractText": ["<i>Annickia chlorantha</i> Setten & P.J.Maas belongs to the Annonaceae family and is a multi-purpose medicinal plant, which has been extensively used for the traditional treatment option for malaria in western and central Africa. Its phytochemical composition is dominated particularly by various biologically active protoberberines and acetogenins. This review aims to provide a comprehensive review on the traditional uses, phytochemical profiles, and the toxicology of this plant from a myriad of available publications. Even after its tremendous applications against several different human ailments, this plant has been underestimated for its anticancer potential. Herein, based on the phytochemical composition, we discuss the probable mode of mechanism for its antiproliferative activity, which highlights its importance for cytotoxicity screenings against cancer cells. Additionally, this article discusses several research questions and suggests the future directions of its applications in medicinal plant-based anticancer research."]}, "AuthorList": [{"Identifier": ["0000-0002-5608-8262"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Johannesburg 2028, South Africa."}], "LastName": "Sarbadhikary", "ForeName": "Paromita", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Johannesburg 2028, South Africa."}], "LastName": "George", "ForeName": "Blassan P", "Initials": "BP"}], "GrantList": [{"GrantID": "Grant No 98337", "Agency": "South African Research Chairs initiative of the Department of science and technology and National Research Foundation of South Africa", "Country": ""}, {"GrantID": "Grant No. SAMRC EIP007/2021", "Agency": "South African Medical Research Council", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bray F., Soerjomataram I. Disease Control Priorities, Third Edition (Volume 3): Cancer. The World Bank; Washington, DC, USA: 2015. The Changing Global Burden of Cancer: Transitions in Human Development and Implications for Cancer Prevention and Control.", "ArticleIdList": ["26913347"]}, {"Citation": "Nikolaou M., Pavlopoulou A., Georgakilas A.G., Kyrodimos E. The challenge of drug resistance in cancer treatment: A current overview. Clin. Exp. Metastasis. 2018;35:309\u2013318. doi: 10.1007/s10585-018-9903-0.", "ArticleIdList": ["10.1007/s10585-018-9903-0", "29799080"]}, {"Citation": "Wang X., Zhang H., Chen X. Drug resistance and combating drug resistance in cancer. Cancer Drug Resist. 2019;2:141\u2013160. doi: 10.20517/cdr.2019.10.", "ArticleIdList": ["10.20517/cdr.2019.10", "PMC8315569", "34322663"]}, {"Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Zhang Z., Zhou L., Xie N., Nice E.C., Zhang T., Cui Y., Huang C. Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct. Target. Ther. 2020;5:113. doi: 10.1038/s41392-020-00213-8.", "ArticleIdList": ["10.1038/s41392-020-00213-8", "PMC7331117", "32616710"]}, {"Citation": "Prakash O., Kumar A., Kumar P., Ajeet A. Anticancer Potential of Plants and Natural Products: A Review. Am. J. Pharmacol. Sci. 2013;1:104\u2013115. doi: 10.12691/ajps-1-6-1.", "ArticleIdList": ["10.12691/ajps-1-6-1"]}, {"Citation": "Hassan B. Medicinal Plants\u2014Use in Prevention and Treatment of Diseases. BoD\u2013Books on Demand; Stockholm, Sweden: 2020. Plants and Cancer Treatment."}, {"Citation": "Mohan L. Alternative Medicine\u2014Update. IntechOpen; London, UK: 2021. Plant-Based Drugs as an Adjuvant to Cancer Chemotherapy."}, {"Citation": "Choudhari A.S., Mandave P.C., Deshpande M., Ranjekar P., Prakash O. Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Front. Pharmacol. 2020;10:1614. doi: 10.3389/fphar.2019.01614.", "ArticleIdList": ["10.3389/fphar.2019.01614", "PMC7025531", "32116665"]}, {"Citation": "Barnum C.R., Endelman B.J., Shih P.M. Utilizing Plant Synthetic Biology to Improve Human Health and Wellness. Front. Plant Sci. 2021;12:1824. doi: 10.3389/fpls.2021.691462.", "ArticleIdList": ["10.3389/fpls.2021.691462", "PMC8421571", "34504505"]}, {"Citation": "Chota A., George B.P., Abrahamse H. Frontiers in Natural Product Chemistry. Bentham Science Publisher; Sharjah, United Arab Emirates: 2021. Plant-Derived Anticancer Compounds Used in Cancer Therapies."}, {"Citation": "Yuan H., Ma Q., Ye L., Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21:559. doi: 10.3390/molecules21050559.", "ArticleIdList": ["10.3390/molecules21050559", "PMC6273146", "27136524"]}, {"Citation": "Garcia-Oliveira P., Otero P., Pereira A.G., Chamorro F., Carpena M., Echave J., Fraga-Corral M., Simal-Gandara J., Prieto M.A. Status and challenges of plant-anticancer compounds in cancer treatment. Pharmaceuticals. 2021;14:157. doi: 10.3390/ph14020157.", "ArticleIdList": ["10.3390/ph14020157", "PMC7918405", "33673021"]}, {"Citation": "Krishnamurti C., Chakra Rao S.S.C. The isolation of morphine by Serturner. Indian J. Anaesth. 2016;60:861\u2013862. doi: 10.4103/0019-5049.193696.", "ArticleIdList": ["10.4103/0019-5049.193696", "PMC5125194", "27942064"]}, {"Citation": "Newman D.J., Cragg G.M. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J. Nat. Prod. 2020;83:770\u2013803. doi: 10.1021/acs.jnatprod.9b01285.", "ArticleIdList": ["10.1021/acs.jnatprod.9b01285", "32162523"]}, {"Citation": "Mahomoodally M.F. Traditional medicines in Africa: An appraisal of ten potent African medicinal plants. Evid. Based Complementary Altern. Med. 2013;2013:617459. doi: 10.1155/2013/617459.", "ArticleIdList": ["10.1155/2013/617459", "PMC3866779", "24367388"]}, {"Citation": "Kuete V., Efferth T. African flora has the potential to fight multidrug resistance of cancer. BioMed Res. Int. 2015;2015:914813. doi: 10.1155/2015/914813.", "ArticleIdList": ["10.1155/2015/914813", "PMC4413252", "25961047"]}, {"Citation": "Iwu M.M. Handbook of African Medicinal Plants. 2nd ed. CRC Press; Boca Raton, FL, USA: 2014."}, {"Citation": "Lall N. Underexplored Medicinal Plants from Sub-Saharan Africa: Plants with Therapeutic Potential for Human Health. Academic Press; Cambridge, MA, USA: 2019."}, {"Citation": "Olivier D.K., Van Vuuren S.F., Moteetee A.N. Annickia affinis and A. chlorantha (Enantia chlorantha)\u2014A review of two closely related medicinal plants from tropical Africa. J. Ethnopharmacol. 2015;176:438\u2013462. doi: 10.1016/j.jep.2015.10.021.", "ArticleIdList": ["10.1016/j.jep.2015.10.021", "26481608"]}, {"Citation": "Davares A.K.L., Arsene M.M.J., Viktorovna P.I., Shommya D. Enantia chlorantha and its Multiple Therapeutic Virtues: A Mini Review. J. Pharm. Res. Int. 2021;33:254\u2013259. doi: 10.9734/jpri/2021/v33i45A32741.", "ArticleIdList": ["10.9734/jpri/2021/v33i45A32741"]}, {"Citation": "Akinwale S.G., Chukwu O.E., Chioma O.P., Chukudi A.J., Olubunmi A.G. Enantia chlorantha: A review. J. Pharmacogn. Phytochem. 2022;11:34\u201338. doi: 10.22271/phyto.2022.v11.i3a.14406.", "ArticleIdList": ["10.22271/phyto.2022.v11.i3a.14406"]}, {"Citation": "Dawodu A.O., Moses U.D., Apena A., Adetoro A., Dairo J.O. The Proximate Evaluation and Phytochemistry of Enantia chlorantha Stem Bark in Aqueous and Ethanolic Extract. Middle-East J. Sci. Res. 2014;21:2145\u20132148."}, {"Citation": "Adesokan A.A., Yakubu M.T., Owoyele B.V., Akanji M.A., Soladoye A.O., Lawal O.K. Effect of administration of aqueous and ethanolic extracts of Enantia chlorantha stem bark on brewer\u2019s yeast-induced pyresis in rats. Afr. J. Biochem. Res. 2008;2:165\u2013169."}, {"Citation": "Olanlokun J.O., Akomolafe S.F. Antioxidant potentials of various solvent extracts from stem bark of Enantia chlorantha. J. Biomed. Sci. Eng. 2013;06:877\u2013884. doi: 10.4236/jbise.2013.69107.", "ArticleIdList": ["10.4236/jbise.2013.69107"]}, {"Citation": "Odoh U., Okwor I., Ezejiofor M. Phytochemical, trypanocidal and anti-microbial studies of Enantia chlorantha (Annonaceae) root. J. Pharm. Allied Sci. 2011;7:4. doi: 10.4314/jophas.v7i4.63458.", "ArticleIdList": ["10.4314/jophas.v7i4.63458"]}, {"Citation": "Gill L.S., Akinwumi C. Nigerian folk medicine: Practices and beliefs of the ondo people. J. Ethnopharmacol. 1986;18:257\u2013266. doi: 10.1016/0378-8741(86)90004-8.", "ArticleIdList": ["10.1016/0378-8741(86)90004-8", "3821140"]}, {"Citation": "Menut C., Bessi\u00e8re J.M., Lamaty G., Zollo P.H.A., F\u00e9kam F.B., Chalchat J.C., Garry R.P. Aromatic plants of tropical central africa. Part VII. A comparative study of the volatile constituents of the stem bark of Enantia chlorantha oliv. and Xylopia staudtii engl. & diels from cameroon. Flavour Fragr. J. 1992;7:259\u2013261. doi: 10.1002/ffj.2730070505.", "ArticleIdList": ["10.1002/ffj.2730070505"]}, {"Citation": "Nyegue M., Amvam-Zollo P.H., Etoa F.X., Agnaniet H., Chantal M. Chemical and biological investigations of essential oils from stem barks of Enantia chlorantha Oliv. and Polyalthia suaveolens Engler. & Diels. from Cameroon. Nat. Prod. Commun. 2008;3:1934578X0800300711. doi: 10.1177/1934578x0800300711.", "ArticleIdList": ["10.1177/1934578x0800300711"]}, {"Citation": "Boyom F.F., Kemgne E.M., Tepongning R., Ngouana V., Mbacham W.F., Tsamo E., Zollo P.H.A., Gut J., Rosenthal P.J. Antiplasmodial activity of extracts from seven medicinal plants used in malaria treatment in Cameroon. J. Ethnopharmacol. 2009;123:483\u2013488. doi: 10.1016/j.jep.2009.03.008.", "ArticleIdList": ["10.1016/j.jep.2009.03.008", "19442463"]}, {"Citation": "Kemgne E.A.M., Mbacham W.F., Boyom F.F., Zollo P.H.A., Tsamo E., Rosenthal P.J. In vitro sensitivity of Plasmodium falciparum field isolates to extracts from Cameroonian Annonaceae plants. Parasitol. Res. 2012;110:109\u2013117. doi: 10.1007/s00436-011-2456-7.", "ArticleIdList": ["10.1007/s00436-011-2456-7", "21739316"]}, {"Citation": "Agomo P.U., Idigo J.C., Afolabi B.M. \u201cAntimalarial\u201d medicinal plants and their impact on cell populations in various organs of mice. Afr. J. Med. Med. Sci. 1992;21:39\u201346.", "ArticleIdList": ["1308080"]}, {"Citation": "Agbaje E.O., Onabanjo A.O. Toxicological study of the extracts of anti-malarial medicinal plant Enantia chlorantha. Cent. Afr. J. Med. 1994;40:71\u201373.", "ArticleIdList": ["7923347"]}, {"Citation": "Tan P.V., Boda M., Enow-Orock G.E., Etoa F.X., Bitolog P. Acute and sub-acute toxicity profile of the aqueous stem bark extract Enantia chlorantha Oliver (Annonaceae) in laboratory animals. Pharmacologyonline. 2007;1:304\u2013313."}, {"Citation": "Adebiyi O.E., Abatan M.O. Phytochemical and acute toxicity of ethanolic extract of Enantia chlorantha (oliv) stem bark in albino rats. Interdiscip. Toxicol. 2013;6:145\u2013151. doi: 10.2478/intox-2013-0023.", "ArticleIdList": ["10.2478/intox-2013-0023", "PMC3967441", "24678252"]}, {"Citation": "Akintonwa A., Awodele O., Afolayan G., Coker H.A.B. Mutagenic screening of some commonly used medicinal plants in Nigeria. J. Ethnopharmacol. 2009;125:461\u2013470. doi: 10.1016/j.jep.2009.07.013.", "ArticleIdList": ["10.1016/j.jep.2009.07.013", "19619631"]}, {"Citation": "Mesmine K.M., George E.-O., Christophe M., Ernestine N.T.E.Z., Benjamin N., Siwe G., Paul T. Evaluation of the toxicity of the aqueous stem bark extract of Enantia chlorantha on some reproductive and developmental parameters. J. Med. Plants Stud. 2020;8:86\u201394."}, {"Citation": "Moody J.O., Ogundipe O.D., Akang E.U., Agbedana E.O. Toxicological studies on the purified protoberberine alkaloidal fraction of Enantia chlorantha Oliv (ANNONACEAE) Afr. J. Med. Med. Sci. 2007;36:317\u2013323.", "ArticleIdList": ["18564647"]}, {"Citation": "Kuete V. Toxicological Survey of African Medicinal Plants. Elsevier; Amsterdam, The Netherlands: 2014. Health Effects of Alkaloids from African Medicinal Plants."}, {"Citation": "Tene Tcheghebe O., Ngouafong Tatong F., Jackson Seukep A., Author C. Tene Tcheghebe O, Ngouafong Tatong F, Seukep AJ. Traditional uses, phytochemical and pharmacological profiles, and toxicity of Enantia chlorantha (Oliver): An overview. Edorium J. Med. 2016;3:12\u201318. doi: 10.5348/M05-2016-4-RA-2.", "ArticleIdList": ["10.5348/M05-2016-4-RA-2"]}, {"Citation": "Wright C.W., Marshall S.J., Russell P.F., Anderson M.M., Phillipson J.D., Kirby G.C., Warhurst D.C., Schiff J.L. In vitro antiplasmodial, antiamoebic, and cytotoxic activities of some monomeric isoquinoline alkaloids. J. Nat. Prod. 2000;63:1638\u20131640. doi: 10.1021/np000144r.", "ArticleIdList": ["10.1021/np000144r", "11141105"]}, {"Citation": "Adesokan A.A., Akanji M.A., Yakubu M.T. Antibacterial potentials of aqueous extract of Enantia chlorantha stem bark. Afr. J. Biotechnol. 2007;6:2502\u20132505. doi: 10.5897/ajb2007.000-2397.", "ArticleIdList": ["10.5897/ajb2007.000-2397"]}, {"Citation": "Tan P.V., Boda M., Etoa F.X. In vitro and in vivo anti-Helicobacter/Campylobacter activity of the aqueous extract of Enantia chlorantha. Pharm. Biol. 2010;48:349\u2013356. doi: 10.3109/13880200903150377.", "ArticleIdList": ["10.3109/13880200903150377", "20645825"]}, {"Citation": "Donfack V.D., Roque S., Trigo G., Fokou P.T., Tchokouaha L.Y., Tsabang N., Zollo P.A., Correia-Neves M., Boyom F.F. Antimycobacterial activity of selected medicinal plants extracts from Cameroon. Int. J. Biol. Chem. Sci. 2014;8:273. doi: 10.4314/ijbcs.v8i1.24.", "ArticleIdList": ["10.4314/ijbcs.v8i1.24"]}, {"Citation": "Nyong E.E., Odeniyi M.A., Moody J.O. In vitro and in vivo antimicrobial evaluation of alkaloidal extracts of Enantia chlorantha stem bark and their formulated ointments. Acta Pol. Pharm. Drug Res. 2015;72:14\u201352.", "ArticleIdList": ["25850210"]}, {"Citation": "Abike T.O., Osuntokun O.T., Modupe A.O., Adenike A.F., Atinuke A.R. Antimicrobial Efficacy, Secondary Metabolite Constituents, Ligand Docking of Enantia chlorantha on Selected Multidrug Resistance Bacteria and Fungi. J. Adv. Biol. Biotechnol. 2020;23:17\u201332. doi: 10.9734/jabb/2020/v23i630161.", "ArticleIdList": ["10.9734/jabb/2020/v23i630161"]}, {"Citation": "Agbaje E., Tijani A., Braimoh O. Effects of Enantia chlorantha extracts in Laboratory-Induced Convulsion and Inflammation. Orient J. Med. 2004;15:68\u201371. doi: 10.4314/ojm.v15i1.29050.", "ArticleIdList": ["10.4314/ojm.v15i1.29050"]}, {"Citation": "Njayou F., Moundipa P., Tchana A., Ngadjui B., Tchouanguep F. Inhibition Of Microsomal Lipid Peroxidation And Protein Oxidation By Extracts From Plants Used In Bamun Folk Medicine (Cameroon) Against Hepatitis. Afr. J. Tradit. Complement. Altern. Med. 2008;5:278\u2013289. doi: 10.4314/ajtcam.v5i3.31284.", "ArticleIdList": ["10.4314/ajtcam.v5i3.31284", "PMC2816548", "20161949"]}, {"Citation": "Muganza D.M., Fruth B., Lami J.N., Mesia G., Kambu O., Tona G., Kanyanga R.C., Cos P., Maes L., Apers S., et al. In vitro antiprotozoal and cytotoxic activity of 33 ethonopharmacologically selected medicinal plants from Democratic Republic of Congo. J. Ethnopharmacol. 2012;141:301\u2013308. doi: 10.1016/j.jep.2012.02.035.", "ArticleIdList": ["10.1016/j.jep.2012.02.035", "22394563"]}, {"Citation": "Vennerstrom J.L., Lovelace J.K., Waits V.B., Hanson W.L., Klayman D.L. Berberine derivatives as antileishmanial drugs. Antimicrob. Agents Chemother. 1990;34:918\u2013921. doi: 10.1128/AAC.34.5.918.", "ArticleIdList": ["10.1128/AAC.34.5.918", "PMC171721", "2360830"]}, {"Citation": "Nkwengoua E.T., Ngantchou I., Nyasse B., Denier C., Blonski C., Schneider B. In vitro inhibitory effects of palmatine from Enantia chlorantha on Trypanosoma cruzi and Leishmania infantum. Nat. Prod. Res. 2009;23:1144\u20131150. doi: 10.1080/14786410902726241.", "ArticleIdList": ["10.1080/14786410902726241", "19662580"]}, {"Citation": "Agbaje E.O., Onabanjo A.O. The effects of extracts of Enantia chlorantha in malaria. Ann. Trop. Med. Parasitol. 1991;85:585\u2013590. doi: 10.1080/00034983.1991.11812613.", "ArticleIdList": ["10.1080/00034983.1991.11812613", "1811435"]}, {"Citation": "Kimbi H.K., Fagbenro-Beyioku A.F. Efficacy of Cymbopogon giganteus and Enantia chrantha against chloroquine resistant Plasmodium yoelii nigeriensis. East Afr. Med. J. 1996;73:636\u2013637.", "ArticleIdList": ["8997841"]}, {"Citation": "Kimbi H.K., Fagbenro-Beyioku A.F., Oyibo W.A. Antimalarial herbs against chloroquine-resistant P. yoelii nigeriensis in mice. Indian J. Malariol. 1998;35:35\u201338.", "ArticleIdList": ["10319560"]}, {"Citation": "Adebajo A.C., Famuyiwa F.G., Aliyu F.A. Properties for sourcing nigerian larvicidal plants. Molecules. 2014;19:8363\u20138372. doi: 10.3390/molecules19068363.", "ArticleIdList": ["10.3390/molecules19068363", "PMC6271722", "24950440"]}, {"Citation": "Vennerstrom J.L., Klayman D.L. Protoberberine Alkaloids as Antimalarials. J. Med. Chem. 1988;31:1084\u20131087. doi: 10.1021/jm00401a006.", "ArticleIdList": ["10.1021/jm00401a006", "3286870"]}, {"Citation": "Nurain I., Ibitoye O., Bewaji C.O. Molecular docking analysis of secondary metabolites of stem bark of Enantia chlorantha with human calcium pump. J. Proteins Proteom. 2018;9:1."}, {"Citation": "Agbaje E., Onabanjo A. Analgesic and Antipyretic Actions of Enantia chlorantha Extract in Some Laboratory Animals. Niger. J. Nat. Prod. Med. 1998;2:24\u201325. doi: 10.4314/njnpm.v2i1.11776.", "ArticleIdList": ["10.4314/njnpm.v2i1.11776"]}, {"Citation": "Nyasse B., Nkwengoua E., Sondengam B., Denier C., Willson M. Modified berberine and protoberberines from Enantia chlorantha as potential inhibitors of Trypanosoma brucei. Pharmazie. 2002;57:358\u2013361. doi: 10.1002/chin.200241210.", "ArticleIdList": ["10.1002/chin.200241210", "12116870"]}, {"Citation": "Siminialayi I., Agbaje E. Gastroprotective effects of the ethanolic extract of Enantia chlorantha in rats. West Afr. J. Pharmacol. Drug Res. 2005;20:35\u201338. doi: 10.4314/wajpdr.v20i1.14743.", "ArticleIdList": ["10.4314/wajpdr.v20i1.14743"]}, {"Citation": "Tan P.V., Nyasse B., Enow-Orock G.E., Wafo P., Forcha E.A. Prophylactic and healing properties of a new anti-ulcer compound from Enantia chlorantha in rats. Phytomedicine. 2000;7:291\u2013296. doi: 10.1016/S0944-7113(00)80046-X.", "ArticleIdList": ["10.1016/S0944-7113(00)80046-X", "10969722"]}, {"Citation": "Tan P.V., Nyasse B., Dimo T., Wafo P., Akahkuh B.T. Synergistic and potentiating effects of ranitidine and two new anti-ulcer compounds from Enantia chlorantha and Voacanga africana in experimental animal models. Pharmazie. 2002;57:409\u2013412. doi: 10.1002/chin.200241211.", "ArticleIdList": ["10.1002/chin.200241211", "12116879"]}, {"Citation": "Virtanen P., Lassila V., Njimi T., Mengata D.E. Natural protoberberine alkaloids from enantia chlorantha, palmatine, columbamine and jatrorrhizine for thioacetamide-traumatized rat liver. Cells Tissues Organs. 1988;131:166\u2013170. doi: 10.1159/000146507.", "ArticleIdList": ["10.1159/000146507", "3369286"]}, {"Citation": "Virtanen P., Lassila V., Njimi T., Mengata D.E. Regeneration of D-Galactosamine-Traumatized Rat Liver with Natural Protoberberine Alkaloids from Enantia chlorantha. Cells Tissues Organs. 1988;132:159\u2013163. doi: 10.1159/000146568.", "ArticleIdList": ["10.1159/000146568", "3414361"]}, {"Citation": "Adebiyi O.E., Abatan M.O. Protective Effects of Enantia chlorantha Stem Bark Extracts on Acetaminophen Induced Liver Damage in Rats. Jordan J. Biol. Sci. 2013;6:284\u2013290. doi: 10.12816/0001627.", "ArticleIdList": ["10.12816/0001627"]}, {"Citation": "Salman T.M., Adesokan A.A. Sperm quality of male rats treated with aqueous extract of Enantia chlorantha stem bark. Afr. J. Biotechnol. 2008;7:7."}, {"Citation": "Saalu LC O.A. Testiculo-Protective Effect of Stem Bark Extract of Enantia chlorantha on Lead Induced Toxicity in Adult Wistar Rat (Rattus norvergicus) Reprod. Syst. Sex. Disord. 2012;1:2. doi: 10.4172/2161-038X.1000107.", "ArticleIdList": ["10.4172/2161-038X.1000107"]}, {"Citation": "Alford C.M., Onyejiaka A., Myles E.L. Abstract 614: Cytotoxic activity of Enantia chlorantha, nauclea latifolia, and citrus medica extracts on carcinoma cells. Cancer Res. 2016;76:614. doi: 10.1158/1538-7445.AM2016-614.", "ArticleIdList": ["10.1158/1538-7445.AM2016-614"]}, {"Citation": "Tshibangu D.S., Divakar S., Ramanathan M., Syamala G., Ngbolua K.-T., Mudogo J.C.V., Tshilanda D.D., Misengabu N.M., Mpiana P.T. In Vitro Anticancer Assessment of Annickia chlorantha (Oliv.) Setten & Maas Stem (Annonaceae) Bark from Democratic Republic of Congo. J. Biosci. Med. 2016;04:23\u201329. doi: 10.4236/jbm.2016.44004.", "ArticleIdList": ["10.4236/jbm.2016.44004"]}, {"Citation": "Kuete V., Fokou F.W., Karaosmano\u011flu O., Beng V.P., Sivas H. Cytotoxicity of the methanol extracts of Elephantopus mollis, Kalanchoe crenata and 4 other Cameroonian medicinal plants towards human carcinoma cells. BMC Complement. Altern. Med. 2017;17:280. doi: 10.1186/s12906-017-1793-1.", "ArticleIdList": ["10.1186/s12906-017-1793-1", "PMC5445369", "28545532"]}, {"Citation": "Virtanen P., Lassila V., S\u00f6derstr\u00f6m K.O. Protoberberine alkaloids from Enantia chlorantha therapy of allyl-alcohol- and D-galactosamine-traumatized rats. Pathobiology. 1993;61:51\u201356. doi: 10.1159/000163761.", "ArticleIdList": ["10.1159/000163761", "8216823"]}, {"Citation": "Qing Z.-X., Huang J.-L., Yang X.-Y., Liu J.-H., Cao H.-L., Xiang F., Cheng P., Zeng J.-G. Anticancer and Reversing Multidrug Resistance Activities of Natural Isoquinoline Alkaloids and their Structure-activity Relationship. Curr. Med. Chem. 2017;25:5088\u20135114. doi: 10.2174/0929867324666170920125135.", "ArticleIdList": ["10.2174/0929867324666170920125135", "28933285"]}, {"Citation": "Wang Y., Liu Y., Du X., Ma H., Yao J. The anti-cancer mechanisms of berberine: A review. Cancer Manag. Res. 2020;12:695\u2013702. doi: 10.2147/CMAR.S242329.", "ArticleIdList": ["10.2147/CMAR.S242329", "PMC6996556", "32099466"]}, {"Citation": "Casey S.C., Amedei A., Aquilano K., Azmi A.S., Benencia F., Bhakta D., Bilsland A.E., Boosani C.S., Chen S., Ciriolo M.R., et al. Cancer prevention and therapy through the modulation of the tumor microenvironment. Semin. Cancer Biol. 2015;35:S199\u2013S223. doi: 10.1016/j.semcancer.2015.02.007.", "ArticleIdList": ["10.1016/j.semcancer.2015.02.007", "PMC4930000", "25865775"]}, {"Citation": "Kettmann V., Ko\u0161t\u2019\u00e1lov\u00e1 D., H\u00f6ltje H.D. Human topoisomerase I poisoning: Docking protoberberines into a structure-based binding site model. J. Comput. Aided. Mol. Des. 2004;18:785\u2013796. doi: 10.1007/s10822-004-7878-1.", "ArticleIdList": ["10.1007/s10822-004-7878-1", "16075310"]}, {"Citation": "Bailon-Moscoso N., Cevallos-Solorzano G., Romero-Benavides J., Orellana M.R. Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies. Curr. Genom. 2017;18:106\u2013131. doi: 10.2174/1389202917666160808125645.", "ArticleIdList": ["10.2174/1389202917666160808125645", "PMC5345333", "28367072"]}, {"Citation": "Zhu Y., Xie N., Chai Y., Nie Y., Liu K., Liu Y., Yang Y., Su J., Zhang C. Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer. Front. Pharmacol. 2022;13:803717. doi: 10.3389/fphar.2022.803717.", "ArticleIdList": ["10.3389/fphar.2022.803717", "PMC8830521", "35153781"]}, {"Citation": "Farooqi A.A., Qureshi M.Z., Khalid S., Attar R., Martinelli C., Uteuliyev Y.S., Sadykov B.N., Taverna S., Poltronieri P., Xu B. Regulation of cell signaling pathways by berberine in different cancers: Searching for missing pieces of an incomplete JIG-saw puzzle for an effective cancer therapy. Cancers. 2019;11:478. doi: 10.3390/cancers11040478.", "ArticleIdList": ["10.3390/cancers11040478", "PMC6521278", "30987378"]}, {"Citation": "Zhang C., Sheng J., Li G., Zhao L., Wang Y., Yang W., Yao X., Sun L., Zhang Z., Cui R. Effects of berberine and its derivatives on cancer: A systems pharmacology review. Front. Pharmacol. 2020;10:1461. doi: 10.3389/fphar.2019.01461.", "ArticleIdList": ["10.3389/fphar.2019.01461", "PMC6974675", "32009943"]}, {"Citation": "Och A., Podg\u00f3rski R., Nowak R. Biological Activity of Berberine\u2014A Summary Update. Toxins. 2020;12:713. doi: 10.3390/toxins12110713.", "ArticleIdList": ["10.3390/toxins12110713", "PMC7697704", "33198257"]}, {"Citation": "Bao M., Cao Z., Yu D., Fu S., Zhang G., Yang P., Pan Y., Yang B., Han H., Zhou Q. Columbamine suppresses the proliferation and neovascularization of metastatic osteosarcoma U2OS cells with low cytotoxicity. Toxicol. Lett. 2012;215:174\u2013180. doi: 10.1016/j.toxlet.2012.10.015.", "ArticleIdList": ["10.1016/j.toxlet.2012.10.015", "23124089"]}, {"Citation": "Guo P., Cai C., Wu X., Fan X., Huang W., Zhou J., Wu Q., Huang Y., Zhao W., Zhang F., et al. An insight into the molecular mechanism of berberine towards multiple cancer types through systems pharmacology. Front. Pharmacol. 2019;10:857. doi: 10.3389/fphar.2019.00857.", "ArticleIdList": ["10.3389/fphar.2019.00857", "PMC6691338", "31447670"]}, {"Citation": "Lei C., Yao Y., Shen B., Liu J., Pan Q., Liu N., Li L., Huang J., Long Z., Shao L. Columbamine suppresses the proliferation and malignization of colon cancer cells via abolishing Wnt/\u03b2-catenin signaling pathway. Cancer Manag. Res. 2019;11:8635\u20138645. doi: 10.2147/CMAR.S209861.", "ArticleIdList": ["10.2147/CMAR.S209861", "PMC6764743", "31572013"]}, {"Citation": "Tarabasz D., Kukula-Koch W. Palmatine: A review of pharmacological properties and pharmacokinetics. Phyther. Res. 2020;34:33\u201350. doi: 10.1002/ptr.6504.", "ArticleIdList": ["10.1002/ptr.6504", "31496018"]}, {"Citation": "Yang T., Wei L., Ma X., Ke H. Columbamine suppresses proliferation and invasion of melanoma cell A375 via HSP90-mediated STAT3 activation. J. Recept. Signal Transduct. 2020;41:99\u2013104. doi: 10.1080/10799893.2020.1794003.", "ArticleIdList": ["10.1080/10799893.2020.1794003", "32669028"]}, {"Citation": "Rauf A., Abu-Izneid T., Khalil A.A., Imran M., Shah Z.A., Bin Emran T., Mitra S., Khan Z., Alhumaydhi F.A., Aljohani A.S.M., et al. Berberine as a potential anticancer agent: A comprehensive review. Molecules. 2021;26:7368. doi: 10.3390/molecules26237368.", "ArticleIdList": ["10.3390/molecules26237368", "PMC8658774", "34885950"]}, {"Citation": "Zhong F., Chen Y., Chen J., Liao H., Li Y., Ma Y. Jatrorrhizine: A Review of Sources, Pharmacology, Pharmacokinetics and Toxicity. Front. Pharmacol. 2022;12:783127. doi: 10.3389/fphar.2021.783127.", "ArticleIdList": ["10.3389/fphar.2021.783127", "PMC8793695", "35095493"]}, {"Citation": "Alali F.Q., Liu X.X., McLaughlin J.L. Annonaceous acetogenins: Recent progress. J. Nat. Prod. 1999;62:783127. doi: 10.1021/np980406d.", "ArticleIdList": ["10.1021/np980406d", "10096871"]}, {"Citation": "Bermejo A., Figad\u00e8re B., Zafra-Polo M.C., Barrachina I., Estornell E., Cortes D. Acetogenins from annonaceae: Recent progress in isolation, synthesis and mechanisms of action. Nat. Prod. Rep. 2005;22:269\u2013303. doi: 10.1039/B500186M.", "ArticleIdList": ["10.1039/B500186M", "15806200"]}, {"Citation": "Jacobo-Herrera N., P\u00e9rez-Plasencia C., Castro-Torres V.A., Mart\u00ednez-V\u00e1zquez M., Gonz\u00e1lez-Esquinca A.R., Zentella-Dehesa A. Selective Acetogenins and Their Potential as Anticancer Agents. Front. Pharmacol. 2019;10:783. doi: 10.3389/fphar.2019.00783.", "ArticleIdList": ["10.3389/fphar.2019.00783", "PMC6657400", "31379567"]}, {"Citation": "Lima N.N.d.C., Faustino D.C., Allahdadi K.J., Fran\u00e7a L.S.D.A., Pinto L.C. Acetogenins from Annonaceae plants: Potent antitumor and neurotoxic compounds. PharmaNutrition. 2022;20:100295. doi: 10.1016/j.phanu.2022.100295.", "ArticleIdList": ["10.1016/j.phanu.2022.100295"]}, {"Citation": "Khan T., Gurav P. PhytoNanotechnology: Enhancing delivery of plant based anti-cancer drugs. Front. Pharmacol. 2018;8:1002. doi: 10.3389/fphar.2017.01002.", "ArticleIdList": ["10.3389/fphar.2017.01002", "PMC5811929", "29479316"]}, {"Citation": "More M.P., Pardeshi S.R., Pardeshi C.V., Sonawane G.A., Shinde M.N., Deshmukh P.K., Naik J.B., Kulkarni A.D. Recent advances in phytochemical-based Nano-formulation for drug-resistant Cancer. Med. Drug Discov. 2021;10:100082. doi: 10.1016/j.medidd.2021.100082.", "ArticleIdList": ["10.1016/j.medidd.2021.100082"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "18"}, {"Year": "2022", "Month": "8", "Day": "31"}, {"Year": "2022", "Month": "8", "Day": "31"}, {"Year": "2022", "Month": "9", "Day": "9", "Hour": "1", "Minute": "24"}, {"Year": "2022", "Month": "9", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "10", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "9", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["36079675", "PMC9460708", "10.3390/plants11172293", "plants11172293"]}}], "PubmedBookArticle": []}